Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Price to Book Value (P/BV)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

UnitedHealth Group Inc., P/BV, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of UnitedHealth Group Inc. Annual Report.


The price-to-book value (P/BV) ratio for the period examined exhibits considerable fluctuation, generally trending upwards over the long term but with notable periods of decline. Initial values indicate a relatively high valuation, followed by a period of contraction, and then a resurgence culminating in a peak before a recent downturn.

Initial Period (2006-2009)
From 2006 to 2009, the P/BV ratio demonstrates a consistent downward trend, decreasing from 4.50 to 1.67. This suggests a decreasing market valuation relative to the company’s book value, potentially reflecting broader economic conditions or company-specific concerns during that timeframe. The most significant decline occurred between 2008 and 2009.
Stabilization and Moderate Growth (2010-2017)
Following 2009, the P/BV ratio experienced a period of stabilization and moderate growth, rising from 1.67 to 3.98 by 2017. While not consistently increasing, the ratio generally trended upwards, indicating improving investor confidence and a strengthening market valuation relative to book value. The growth was not linear, with some years showing minimal change.
Peak and Subsequent Decline (2018-2024)
The P/BV ratio reached its peak in 2018 at 4.59 and continued to climb to 6.27 in 2021, before beginning a decline. From 2021 to 2024, the ratio decreased from 6.27 to 4.63. This recent decline suggests a potential shift in market sentiment, possibly due to changing economic conditions, increased competition, or company-specific challenges. The decline appears to be accelerating in the most recent period.
Projected Values (2025-2026)
The projected P/BV ratio for 2025 and 2026 indicates a continued downward trend, falling to 2.84 and then 2.94. This suggests that the market anticipates a further decrease in valuation relative to book value. These projections, however, are subject to change based on future performance and market conditions.

Overall, the P/BV ratio demonstrates a cyclical pattern. While the ratio has historically shown the capacity for recovery and growth, the recent decline and projected values warrant further investigation to understand the underlying drivers and potential implications for future performance.


Comparison to Competitors

UnitedHealth Group Inc., P/BV, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

UnitedHealth Group Inc., P/BV, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)